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40a Sunday, March 6, 2011family proteins, the cytotoxic effects of these BH3 peptides can be reduced in
certain cancer cells. We recently found that the amphipathic tail-anchoring pep-
tide (ATAP) from Bfl-1, a bifunctional Bcl-2 family member, displayed strong
pro-apoptotic activity by permeabilizing the mitochondrial outer membrane
(MOM). Here we tested if the activity of ATAP requires other cellular factors
and whether ATAP has an advantage over the BH3 peptides in targeting cancer
cells. We reconstituted the membrane permeabilizing activity of ATAP in lipo-
somes and found that ATAP rapidly released fluorescent molecules of the size
of cytochrome c, suggesting that ATAP membrane permeabilizing activity is
independent of other protein factors. Confocal microscopic imaging revealed
specific targeting of ATAP toMOM, whereas BH3-peptides showed diffuse cy-
tosolic distribution. While the pro-apoptotic activity of BH3 peptides was
largely inhibited by either overexpression of Bcl-2 or Bcl-xL or nullification
of Bax and Bak in cells, the apoptotic function of ATAP was not affected by
these cellular factors. Since ATAP can target to mitochondria membrane and
its potent apoptotic activity does not dependent on the content of Bcl-2 family
proteins, it represents a promising lead for a new class of anti-cancer drugs that
can potentially overcome the intrinsic apoptosis-resistant nature of cancer cells.
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Biophysical Characterization of Peptide Membrane Interactions and
Membrane Permeabilization
Pranav Garg, Suren A. Tatulian, Annette R. Khaled, Kathleen N. Nemec.
Certain membrane-active amphipathic peptides, such as antimicrobial peptides,
possess a characteristic feature of having several cationic amino acid residues
at either N- or C-terminus. In an attempt to determine the functional signifi-
cance of C-terminal cationic residues, we have studied the membrane binding
mode and membrane pore formation by a 20-amino acid synthetic amphipathic
peptide. Two cationic residues were replaced to Leu or Glu to see how the
membrane binding and permeabilization activities of the peptide are modulated
by charge neutralization and charge reversal mutations. The depth of membrane
insertion of the wild type and mutant peptides was determined by measuring the
quenching of the fluorescence of a single, C-terminally located tryptophan by
dibromo-phosphatidylcholines brominated at various positions of the acyl
chains, using pure POPC and 70% POPC þ 30% POPG in lipid vesicles. In
case of pure POPC membranes, Trp in all three peptides was located at around
9 A˚ from the membrane center, while for 30% POPG, Trp was inserted much
deeper. Studies on peptide-mediated calcein release from phospholipid vesicles
were conducted to see if the peptides are able to cause membrane pore forma-
tion and content release. Peptides with positively charged residues showed
maximum calcein release for both lipid compositions whereas negative or hy-
drophobic residues were less effective in vesicle permeabilization. Preliminary
ATR-FTIR experiments using both POPC and POPG have been performed to
identify the orientation of the peptides within the lipid bilayer and their effect of
the lipid order.
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Regulation of Apoptosis at the Mitochondrial Level by Bcl-2 Proteins
Marcus Wallgren, Anders Pedersen, Nguyen Giang, Lenka Beranova´,
Nguyen Linh, Martin Hof, Gerhard Gro¨bner.
During the life-time of higher organisms the turnover of the cell mass has to be
highly regulated by apoptosis, one of the main types of programmed cell death.
The anti-apoptotic integral membrane protein Bcl-2 belongs to the Bcl-2 pro-
tein family, which functions as a major gatekeeper in the mitochondrial apopto-
tic pathway. This protein has been found to be highly over-expressed in breast
cancer tumors and also been shown to be involved in the inherent resistance to
anti-cancer drugs. Our aim is to work with the full-length Bcl-2 protein and
study its interplay with both, its mitochondrial membrane environment and
the pro-apoptotic Bcl-2 family protein Bax. Bax is the counter-player of
Bcl-2 and is upon activation translocated from the cytosol to the mitochondrial
outer membrane where it forms oligomers. These oligomers function as pores
which enable the release of cytochrome c to the cytosol, followed by initiation
of the caspase activation cascade and subsequently cell death.So far we have
been working on the expression and purification of Bax and Bcl-2, and man-
aged to isolate full-length Bax using E. coli as expression system. For Bcl-2
we have performed cell free expression, and have succeeded in the purification
of the full-length protein, solubilized with detergent. The next step is to char-
acterize the proteins when they are reconstituted into model membrane, using
spectroscopic methods such as CD and 31P solid state NMR spectroscopy. We
are especially interested in how the presence of oxidized lipids influences the
protein-protein and protein-membrane interactions, mimicking the apoptotic
conditions triggered by reactive oxygen species.
Our ultimate goal is to provide structural information of the membrane-medi-
ated mechanism underlying the action of Bcl-2 as a potent inhibitor of cell
death, information crucial for the development of new anti-cancer drugs.209-Pos Board B9
Interactions Between Bcl-2, Bcl-xl, and Bax at the Mitochondria: Keep
Your Friends Close but Your Enemies Closer
Laurent Dejean, Oscar Teijido Hermida, Yogesh Tengarai Ganesan,
Thibaud Renault, Bruno Antonsson, Stephen Manon.
Cytochrome c release, the commitment step of apoptosis, is regulated at the mi-
tochondria through protein-protein interactions between the Bcl-2 family pro-
teins. An imbalance of this interaction network due to the up-regulation of the
proto-oncogenes Bcl-2 and/or Bcl-xL lead to a resistance to apoptosis and is
associated with tumor formation. Bcl-2 or Bcl-xL overexpression act at the
level of the mitochondrial outer membrane (MOM) by inhibiting Bax-mediated
apoptosis; more particularly MAC formation and cytochrome c release. How-
ever, the molecular mechanisms through which Bcl-2 or Bcl-xL affect earlier
steps of Bax-mediated apoptosis are not fully understood. We found that Bax
insertion into the MOM was the earliest apoptotic step inhibited by Bcl-2 over-
expression. However, Bax insertion was not modified if Bcl-xL was overex-
pressed instead of Bcl-2. This suggested Bcl-2 and Bcl-xL have different
functional roles in inhibiting MAC formation. Surprisingly, we also found
that mitochondrial Bax redistribution and change of conformation were not
inhibited but rather spontaneously increased in response of Bcl-2/xL overex-
pression. This increase in mitochondrial associated Bax required a physical
interaction between Bax and Bcl2 or Bcl-xL. We therefore propose that, at least
when up-regulated, Bcl-2 and Bcl-xL behave as Bax receptors which stabilize
Bax binding to the MOM. This sequestration of Bax by Bcl-2/xL would then
consequently increase Bax mitochondrial relocalization, but further inhibit
Bax-mediated MOM permeabilization and later steps of apoptosis.
Supported by NYU Research challenge Funds to LD.
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Demise of the Umbrella Model in BAK-Mediated Mitochondrial Mem-
brane Permeabilization During Apoptosis
Robert Galvin, Sreevidya Aluvila, Steffi Lee, Kyoung Joon Oh.
BCL-2 proteins, including BAX and BAK, play critical roles in apoptosis.
Upon activation by cell death signals, BAX or BAK forms large oligomeric
pores in the mitochondrial outer membrane, permeabilizing mitochondria.
This allows the escape of the cell death factors such as cytochrome c from
the intermembrane space into the cytoplasm, where they execute downstream
cell death events. Using a proteo-liposomal system that recapitulates the
pore-forming processes by BAX or BAK (Oh et al. JBC 2010; 285, 28924-
28937), we previously demonstrated that spin labels attached in the BH3
(Bcl-2 homology domain 3) domain were juxtaposed within 5-10 A˚ distance
in the oligomeric form in the membrane, providing direct evidence for the
existence of the BH3:BH3 contact interface between nearby monomers. We
have further determined the conformational changes in BAK upon membrane
insertion by applying the site-directed spin labeling method of EPR. Pairs of
spin labels introduced at various positions in BAK allowed us to measure the
inter-domain distances before and after the pore-formation. The results show
that BAK unfolds and inserts into the membrane in an unexpected way, con-
trary to the predictions by the ‘‘umbrella model’’ in which the sandwiching
outer layers of the BAK protein open up to expose the core a5-a6 helical hair-
pin for membrane insertion. Our results also indicate that residue 83 in the BH3
domain is in close proximity to the central region of a5 helix (i.e., residue 135)
but is removed from its amino-terminus (i.e., residue 122) within a monomer in
the membrane-inserted oligomeric pore. These results identify a5 helix as the
previously unknown domain in contact with the BH3 domain in the membrane
bound state of BAK (ibid), providing further insights into the mechanism of
BAK (or BAX) dimerization and oligomerization.
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HAX-1: A Multifaceted Family of Apoptotic Regulators
Solomon V. Yap, Jason Koontz, Nicole Perry,
Aikaterini Kontrogianni-Konstantopoulos.
HAX-1 was first identified as a binding partner of HS1, a protein involved in the
maturation of T cells. To date, studies on HAX-1 have mainly focused on the
prototypical variant I protein, demonstrating that it has anti-apoptotic proper-
ties. Recent evidence, however, has indicated that the HAX-1 gene is heavily
spliced, producing a number of isoforms with distinct molecular compositions
and presumably varied functional activities. In light of this observation, we
sought to characterize the different HAX-1 isoforms expressed in rat striated
muscles.
Using 2D gel electrophoresis and RT-PCR analysis, we determined the exis-
tence of at least seven distinct HAX-1 proteins, and further identified five novel
mRNA variants, in addition to the seven known ones, in developing and adult
rat myocardium. Our analysis of the various isoforms revealed profound differ-
ences in their subcellular localization and anti-apoptotic activities. Certain
